Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Commonalities"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
product_txtF_mv:"National Center for Biotechnology Information"
Search alternatives
:
commonalities »
communities
,
commodities
Showing
1
-
20
of
724
Search:
'"Commonalities"'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Glycerol phenylbutyrate (Ravicti)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
2
Propranolol hydrochloride (Hemangiol)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
3
CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
4
CADTH Canadian Drug Expert Committee final recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication : type 2 diabetes
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
5
CADTH Canadian Drug Expert Committee final recommendation: Tiotropium/Olodaterol (Inspiolto Respimat - Boehringer Ingelheim Canada Ltd.) indication : chronic obstructive pulmonary...
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
6
CADTH Canadian Drug Expert Committee final recommendation: Tesamorelin (Egrifta -- Theratechnologies Inc.) indication : HIV-associated lipohypertherapy
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
7
CADTH Canadian Drug Expert Committee final recommendation: Ticagrelor (Brilinta -- AstraZeneca Canada Inc.) indication : secondary prevention of atherothrombotic events
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
8
CADTH Canadian Drug Expert Committee final recommendation: Canagliflozin and metformin hydrochloride (Invokamet -- Janssen Inc.) : type 2 diabetes mellitus
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
9
Ustekinumab (Stelara) injection
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
10
Rotigotine (Neupro) (Transdermal patch)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
11
Simeprevir (Galexos) (150 mg)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
12
Aripiprazole (Abilify) : depression, major depressive disorder (MDD)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
13
Fluticasone furoate/Vilanterol (Breo ellipta)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
14
Galsulfase (Naglazyme)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
15
Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (EVG/COBI/FTC/TAF) (Genvoya) fixed-dose combination, oral tablet
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
16
Mepolizumab (Nucala)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
17
Canakinumab (Ilaris)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
18
Brivaracetam (Brivlera)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
19
Budesonide (Cortiment MMX)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
20
Entyvio (Vedolizumab)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
1
2
3
4
5
6
7
8
9
10
11
Back
Narrow Search
Remove Filters
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
610 - Medicine & health
527
330 - Economics
251
140 - Specific philosophical schools
78
700 - The arts; fine & decorative arts
70
580 - Plants (Botany)
10
615 - Pharmacology & therapeutics
4
Language
English
724
Collection
National Center for Biotechnology Information
Author
Canadian Agency for Drugs and Technologies in Health
665
CADTH Canadian Drug Expert Committee
201
Canadian Diabetes Association
3
Kidney Foundation of Canada
2
Multiple Sclerosis Society of Canada
1
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&lookfor=%22Commonalities%22&type=Series
Send by Email
×
Loading...